Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Neutrophil Lymphocyte Ratio in Estimating Response to Corticosteroid Treatment in Immune Thrombocytopenia Patients
  1. Home
  2. Publications
  3. Neutrophil Lymphocyte Ratio in Estimating Response to Corticosteroid Treatment in Immune Thrombocytopenia Patients

Neutrophil Lymphocyte Ratio in Estimating Response to Corticosteroid Treatment in Immune Thrombocytopenia Patients

Authors:
  • RERafet Eren
    Rafet Eren
  • MÜMehmet Ünaldı
    Mehmet Ünaldı
  • AKAbdülkadir Karışmaz
    Abdülkadir Karışmaz
  • MDMehmet Hilmi Doğu
    Mehmet Hilmi Doğu
  • HKHilal Tan Köker
    Hilal Tan Köker
  • ŞAŞermin Altındal
    Şermin Altındal
  • OYOsman Yokuş
    Osman Yokuş
  • ESElif Suyanı
    Elif Suyanı

Publisher website
Google Scholar
  • 1 January 2019
    • journal article
    • research article
    • Published by Galenos Yayinevi in Istanbul Medical Journal
    • Vol. 20  (1) , 54-57
    • DOI:10.4274/imj.galenos.2018.76158
Abstract
No abstract available
Keywords
  • CORTICOSTEROID
  • IMMUNE THROMBOCYTOPENIA PATIENTS
  • NEUTROPHIL LYMPHOCYTE RATIO
Cited by 2 articles
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.